Tag Archives: National Health Service (NHS)

The urgency of early diagnosis Blair Elliott, Health Innovation West Midlands CVD accounts for 27% of all deaths in the UK,4 and heart failure is also becoming increasingly prevalent, with over 780,000 people on their GP’s heart failure register.5 The earlier a patient begins treatment for CVD or heart failure, the better their chances of reducing hospitalisation and improving outcomes. Each admission not only adds to the strain on the NHS, but also significantly increases the risk of mortality. Timely recognition of acute symptoms and expedited diagnosis must be at the forefront of our efforts. This is why we are supporting initiatives, su

Professor Raj Thakkar The challenging questions we must ask ourselves are: How and why did we reach this status quo? What are the consequences of continuing to operate in the current care model? What should we do about it, by when and how? Are we really offering true value across the whole patient journey (and if we think we are, how do we know)? Do we honestly look outside our own business or service delivery units? Unified value and operational integration Let’s consider value for a moment. Can the NHS deliver true value-based care unless integrated-care systems (ICSs) are operationally integrated; but how can ICSs integrate if individu

Meeting patient needs Dr Rani Khatib Previously, individuals with CV disease and type 2 diabetes in our area were treated by two separate specialty teams. However, it is now well-established that there is significant interplay between CV and metabolic disease, as well as renal disorders.2,3 Thus, we have come to believe that the management of complex post-MI Cardio–Renal–Metabolic or ‘CaReMe’ cases requires a more holistic care model. In this way, we can ensure that patients gain easy access to all required risk and medicine optimisation, and other forms of care, in line with current treatment guidelines, and individually tailored to